Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Can/Fite BioPharma Ltd/ Recent news which mentions Can/Fite BioPharma Ltd/ Multiple Shots On Goal: Can-Fite's Late-Stage Clinical Pipeline Hits Positive Results December 13, 2022 Tickers CANF Tags CANF Market News Penny Stocks From Benzinga This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers October 27, 2022 Tickers AMGN BMY CANF Tags Can/Fite BioPharma Ltd/ Biotech Partner Content From Benzinga Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis? April 12, 2022 Tickers ABBV AMGN CANF NVS Tags ABBV General Biotech From Benzinga This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants March 24, 2022 Tickers AMGN CANF NVS Tags Benzinga AMGN Penny Stocks From Benzinga Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor? February 03, 2022 Tickers ABBV AMGN BMY CANF Tags Penny Stocks Benzinga Market News From Benzinga A New Oral Therapy for Psoriasis Could Be Coming Soon January 24, 2022 Tickers ABBV AMGN CANF NVS Tags NVS Partner Content Can/Fite BioPharma Ltd/ From Benzinga PRIOR TO PHASE III PSORIASIS DATA RELEASE CAN FITE REPORTS THAT PICLIDENOSON DESTROYS PATHOLOGICAL SKIN CELLS IN VITRO January 13, 2022 Tickers CANF Tags General Partner Content Press Releases From Benzinga Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference January 10, 2022 Tickers CANF CFBI Tags Health Care General Partner Content From Benzinga Dawson James - Can-Fite (CANF) Buy Rated - Expected Milestones January 05, 2022 Tickers CANF Tags General Press Releases Biotech From Benzinga CAN-FITE ISSUES LETTER TO SHAREHOLDERS January 05, 2022 Tickers CANF Tags Partner Content Can/Fite BioPharma Ltd/ Press Releases From Benzinga FOLLOWING COMPLETE CLEARANCE OF CANCER LESIONS IN ADVANCED LIVER CANCER PATIENT, CAN-FITE IS FILING PATENT APPLICATIONS FOR THE TREATMENT OF VARIOUS ADVANCED SOLID TUMORS January 03, 2022 Tickers CANF Tags Biotech Press Releases Can/Fite BioPharma Ltd/ From Benzinga Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal October 21, 2021 Tickers CANF CFBI Tags Market News CANF CFBI From Benzinga Hope on the Horizon for Liver Cancer Patients as This Company's Namodenoson Drug Starts Pivotal Phase III Global Trial October 08, 2021 Tickers CANF Tags Penny Stocks Benzinga CANF From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.